Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 1:10 PM
Ignite Modification Date:
2025-12-25 @ 12:23 PM
NCT ID:
NCT03136861
Population Description:
At Baseline Treatment Period 1, 380 patients were randomized to either secukinumab 150 mg or placebo (Group A or B). All the patients who completed Treatment Period 1 (367) were re-randomized or re-assigned respectively to 1 of 5 treatment arms to receive either secukinumab 150 mg or secukinumab 300 mg (Arm A1 to B2) in Treatment Period 2.
Study:
NCT03136861
Study Brief:
Results Section:
NCT03136861